• Over 2,000 immune-oncology drugs now in development pharmatimes
    December 11, 2017
    A new report has found that there are more than 2,000 immunotherapy drugs now in development for cancer, with 940 of these in clinical stage development and 1,064 at the preclinical stage.
PharmaSources Customer Service